the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

RM300 million allocated for land acquisition in S’wak-Sabah link road project – Sarawak Assembly told

KUCHING: A RM300 million allocation has been channelled to the Sarawak Land and Survey Department for land acquisition related to the Sarawak-Sabah Link Road (SSLR) project, said Sarawak Deputy Premier Datuk Amar Awang Tengah Ali Hasan.

Awang Tengah, who is also the Second Minister of Natural Resources and Urban Development, said the land acquisition for the 122-kilometre stretch of the road will be completed by the end of this year.

“The remaining 275.5 km will be completed by 2025,” he said during his winding-up speech at the Sarawak State Legislative Assembly today.

On Nov 4, Deputy Works Minister Datuk Seri Ahmad Maslan was reported to have said that the first phase of the SSLR project, covering the route from Lawas to the Long Lopeng Junction in Sarawak, had achieved 38 per cent progress as of September 2024.

That 77 km stretch from Kampung Gelugus in Lawas to the Long Lopeng Junction is expected to be completed in 2026.

Ahmad Maslan also said the Letter of Acceptance for the second phase of the SSLR project was issued in March this year.

Awang Tengah also said for the Second Trunk Road/Coastal Highway project, RM220 million allocated by the Sarawak government enabled the Land and Survey Department to complete land acquisition for a 255.6 km stretch.

“For the Northern Coastal Highway project, RM20 million allocated by the Sarawak government allowed the Land and Survey Department to complete land acquisition for a six-kilometre stretch by the end of 2023.

“An additional RM140 million is required to complete land acquisition for the remaining 82.7 km,” he added.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings